SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-052485
Filing Date
2020-04-28
Accepted
2020-04-28 17:18:43
Documents
5
Effectiveness Date
2020-04-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2018003d1_defa14a.htm DEFA14A 14161
2 GRAPHIC image_001.jpg GRAPHIC 81863
3 GRAPHIC image_002.jpg GRAPHIC 102493
4 GRAPHIC image_003.jpg GRAPHIC 59395
5 GRAPHIC image_004.jpg GRAPHIC 39255
  Complete submission text file 0001104659-20-052485.txt   405706
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36860 | Film No.: 20826208
SIC: 2836 Biological Products, (No Diagnostic Substances)